Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases
Clinical trial NCT03910361 · COMPLETED
Trial details
- NCT number
- NCT03910361
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-12
- Primary completion
- 2020-07-02
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.